“Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes: A Narrative Review of Who Needs Fibrosis Staging and When”. 2023. Journal of Clinical Diabetes and Obesity 3 (1): 19-24. https://doi.org/10.5281/zenodo.22258263.